metformin has been researched along with Mitochondrial Myopathies in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Mitochondrial Myopathies: A group of muscle diseases associated with abnormal mitochondria function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Lee, YF | 1 |
| Chou, S | 1 |
| Uno, H | 1 |
| Li, G | 1 |
| Brookes, P | 1 |
| Massett, MP | 1 |
| Wu, Q | 1 |
| Chen, LM | 1 |
| Chang, C | 1 |
1 other study available for metformin and Mitochondrial Myopathies
| Article | Year |
|---|---|
Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; Animals; Cells, Cultured; Electron Transport Com | 2011 |